Evidence map›Paper›PMID 27688305›Full record

ReviewCirculation research2016

The Future of Onco-Cardiology: We Are Not Just "Side Effect Hunters".

Jun-Ichi Abe, James F Martin, Edward T H Yeh

Open access · bronzeAbstract readReview
In one paragraph

Review in Circulation research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Long-Term Prognostic Value ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2023
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Atrial Cardiomyopathy and Atrial Fibrillation in Cancer.Cardiology research and practice · 2021
    Review
  8. Article
  9. Article
  10. Review
  11. The Role of NLRP3 Inflammasome in Radiation-Induced Cardiovascular Injury.Frontiers in cell and developmental biology · 2020
    Review
  12. Article
  13. Observational
  14. Article
  15. Radiation Matters of the Heart: A Mini Review.Frontiers in cardiovascular medicine · 2018
    Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jun-Ichi AbeFrom the Department of Cardiology, The University of Texas, MD Anderson Cancer Center, Houston (J.i.A.); Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, TX (J.F.M.); Cardiomyocyte Renewal Laboratory, Texas Heart Institute, Houston (J.F.M.); and Department of Medicine, University of Missouri, Columbia (E.T.H.Y.). jabe@mdanderson.org.
James F MartinFrom the Department of Cardiology, The University of Texas, MD Anderson Cancer Center, Houston (J.i.A.); Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, TX (J.F.M.); Cardiomyocyte Renewal Laboratory, Texas Heart Institute, Houston (J.F.M.); and Department of Medicine, University of Missouri, Columbia (E.T.H.Y.).
Edward T H YehFrom the Department of Cardiology, The University of Texas, MD Anderson Cancer Center, Houston (J.i.A.); Department of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, TX (J.F.M.); Cardiomyocyte Renewal Laboratory, Texas Heart Institute, Houston (J.F.M.); and Department of Medicine, University of Missouri, Columbia (E.T.H.Y.).
Baylor College of Medicine · US

Funding

PAR 13-233 cART accelerates vascular aging in HIV infected subjectsR01HL123346 · NHLBI · UNIVERSITY OF ROCHESTER · PI ABE, JUN-ICHI, MAGGIRWAR, SANJAY B. · 2014 to 2018
$3.7M
Disturbed flow-induced TERF2IP post-translational modifications and atherosclerosis.R01HL130193 · NHLBI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI ABE, JUN-ICHI · 2016 to 2019
$2.0M
p90RSK-ERK5 module, efferocytosis, and vulnerable plaque formationR01HL118462 · NHLBI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI ABE, JUN-ICHI · 2014 to 2018
$2.0M
Doxorubicin-induced Cardiotoxicity: The Role of Topoisomerase 2bR01HL126916 · NHLBI · UNIV OF ARKANSAS FOR MED SCIS · PI YEH, EDWARD T.H. · 2015 to 2018
$1.6M
Ubiquitin-like protein modification in diabetic cardiomyopathyR01HL108551 · NHLBI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI ABE, JUN-ICHI, YANG, JAY · 2011 to 2014
$1.6M
NHLBI NIH HHS R01 HL108551NHLBI NIH HHS R01 HL118462NHLBI NIH HHS R01 HL123346NHLBI NIH HHS R01 HL126916NHLBI NIH HHS R01 HL130193
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAntineoplastic AgentsCardiologyCardiotoxicityCardiovascular DiseasesForecastingHumansMedical OncologyNeoplasmsTelomere ShorteningAntineoplastic Agentsanthracyclinecancer survivorscardiotoxicityheart failurepremature agingsurvivors

Identifiers

PMID27688305
PMCPMC5147506
OpenAlexW2523772416

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.